Progressive supranuclear palsy as differential diagnosis of Parkinson's disease in the elderly.

Autor:	Fernández-Ferreira R; Internal Medicine Department, Médica Sur Clinic & Foundation, PC 14050, Mexico City, Mexico. Electronic address: ricferfer33@gmail.com.mx., García-Santos RA; Neurology Department, National Institute of Neurology and Neurosurgery, PC 14269, Mexico City, Mexico., Rodríguez-Violante M; Clinical Laboratory of Neurodegenerative Diseases, National Institute of Neurology and Neurosurgery, PC 14269, Mexico City, Mexico., López-Martínez C; Geriatrics Department, Médica Sur Clinic & Foundation, PC 14050, Mexico City, Mexico., Becerra-Laparra IK; Geriatrics Department, Médica Sur Clinic & Foundation, PC 14050, Mexico City, Mexico., Torres-Pérez ME; Internal Medicine Department, Médica Sur Clinic & Foundation, PC 14050, Mexico City, Mexico.
Jazyk:	angličtina
Zdroj:	Revista espanola de geriatria y gerontologia [Rev Esp Geriatr Gerontol] 2019 Sep - Oct; Vol. 54 (5), pp. 251-256. Date of Electronic Publication: 2019 Jul 16.
DOI:	10.1016/j.regg.2019.04.002
Abstrakt:	Introduction: Progressive supranuclear palsy (PSP) is a syndrome characterized by progressive parkinsonism with early falls due to postural instability, typically vertical gaze supranuclear ophthalmoplegia, pseudobulbar dysfunction, neck dystonia and upper trunk rigidity as well as mild cognitive dysfunction. Progressive supranuclear palsy must be differentiated from Parkinson's disease taking into account several so-called red flags. Materials and Methods: We report a case series hallmarked by gait abnormalities, falls and bradykinesia in which Parkinson's disease was the initial diagnosis. Results: Due to a torpid clinical course, magnetic resonance imaging (MRI) was performed demonstrating midbrain atrophy, highly suggestive of progressive supranuclear palsy. Conclusion: The neuroradiological exams (magnetic resonance imaging, single photon emission computer tomography, and positron emission tomography) can be useful for diagnosis of PSP. Treatment with levodopa should be considered, especially in patients with a more parkinsonian phenotype. (Copyright © 2019. Publicado por Elsevier España, S.L.U.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu